UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 159

Sortiert nach

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Annals of oncology, 2004-01, Vol.15 (1), p.129-133

2004

Link zum Volltext

Verfügbarkeit prüfen

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(−) EBV(−) HHV8(+) patient

European journal of haematology, 2013-11, Vol.91 (5), p.467-469

2013

Link zum Volltext

Verfügbarkeit prüfen

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Journal of cellular and molecular medicine, 2023-07, Vol.27 (14), p.1928-1946

2023

Link zum Volltext

Verfügbarkeit prüfen

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

British journal of haematology, 2003-05, Vol.121 (3), p.439-447

2003

Link zum Volltext

Verfügbarkeit prüfen

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

British journal of haematology, 1999-10, Vol.107 (1), p.154-161

1999

Link zum Volltext

Verfügbarkeit prüfen

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Haematologica (Roma), 2021-07, Vol.106 (7), p.1923

2021

Link zum Volltext

Verfügbarkeit prüfen

Position paper on the therapeutic use of rituximab in CD20‐positive diffuse large B‐cell non‐Hodgkin's lymphoma

British journal of haematology, 2003-04, Vol.121 (1), p.44-48

2003

Link zum Volltext

Verfügbarkeit prüfen

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

British journal of haematology, 2008-11, Vol.143 (3), p.395-403

2008

Link zum Volltext

Verfügbarkeit prüfen

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

JAAD Case Reports, 2024-06, Vol.48, p.18-22

2024

Link zum Volltext

Verfügbarkeit prüfen

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Cancer, 2010-11, Vol.116 (21), p.5001-5011

2010

Link zum Volltext

Verfügbarkeit prüfen

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group

European journal of haematology, 2008-03, Vol.80 (3), p.227-235

2008

Link zum Volltext

Verfügbarkeit prüfen

Burkitt‐like lymphoma with 11q aberration

Clinical case reports, 2019-09, Vol.7 (9), p.1823-1824

2019

Link zum Volltext

Verfügbarkeit prüfen

Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries

British journal of haematology, 2022-02, Vol.196 (4), p.849-863

2022

Link zum Volltext

Verfügbarkeit prüfen

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Haematologica (Roma), 2011-07, Vol.96 (7), p.1002-1007

2011

Link zum Volltext

Verfügbarkeit prüfen

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Journal of medical case reports, 2020-09, Vol.14 (1), p.138-138, Article 138

2020

Link zum Volltext

Verfügbarkeit prüfen

Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non‐Hodgkin lymphoma

British journal of haematology, 2010-03, Vol.148 (5), p.808-810

2010

Link zum Volltext

Verfügbarkeit prüfen

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

Hematological oncology, 2011-03, Vol.29 (1), p.10-16

2011

Link zum Volltext

Verfügbarkeit prüfen

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

Clinical lymphoma, myeloma and leukemia, 2023-09, Vol.23, p.S54-S56

2023

Link zum Volltext

Verfügbarkeit prüfen

combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma

Annals of hematology, 2009-05, Vol.88 (5), p.425-432

2009

Link zum Volltext

Verfügbarkeit prüfen

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

European journal of haematology, 2000-09, Vol.65 (3), p.188-194

2000

Link zum Volltext

Verfügbarkeit prüfen

ALK-positive large B-cell lymphomas: A clinicopathologic study

Indian journal of pathology & microbiology, 2022-04, Vol.65 (2), p.381-386

2022

Link zum Volltext

Verfügbarkeit prüfen

The role of hematopoietic SCT in adult Burkitt lymphoma

Bone marrow transplantation (Basingstoke), 2013-05, Vol.48 (5), p.617-629

2013

Link zum Volltext

Verfügbarkeit prüfen

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Future oncology (London, England), 2023-04, Vol.19 (11), p.737-738

2023

Link zum Volltext

Verfügbarkeit prüfen

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

Experimental hematology & oncology, 2015-07, Vol.4 (1), p.18, Article 18

2015

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 159

Suche als RSS-Feed

Aktive Filter

ThemaLymphoma, Non-Hodgkin - Drug Therapy

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(148)

Publikationsform

Sprache

Englisch
(157)
Japanisch
(13)

Erscheinungsjahr

n.n

Thema

Science & Technology
(131)
Life Sciences & Biomedicine
(130)
Humans
(103)
Hematology
(78)
Male
(72)
Oncology
(71)
Female
(66)
Adult
(59)
Middle Aged
(59)
Aged
(46)
Lymphoma
(45)
Biological And Medical Sciences
(34)
Lymphoma, Non-Hodgkin - Therapy
(34)
Medical Sciences
(34)
Prognosis
(31)
Adolescent
(30)
Treatment Outcome
(30)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(28)
Aggressive Non-Hodgkin's Lymphoma
(25)
Aggressive Lymphoma
(24)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Incidence and risk factors for central nervous system occurrence in elderly patients with diffuse large-B-cell lymphoma: influence of rituximab

Is valganciclovir really effective in primary effusion lymphoma: case report of an HIV(−) EBV(−) HHV8(+) patient

Long non‐coding RNA as a novel biomarker and therapeutic target in aggressive B‐cell non‐Hodgkin lymphoma: A systematic review

Aurora2/BTAK/STK15 is involved in cell cycle checkpoint and cell survival of aggressive non‐Hodgkin's lymphoma

Allogeneic bone marrow transplantation in aggressive non‐Hodgkin's lymphoma (excluding Burkitt and lymphoblastic lymphoma): a series of 73 patients from the SFGM database

Impact on survival through consolidation radiotherapy for diffuse large B-cell lymphoma: a comprehensive meta-analysis

Position paper on the therapeutic use of rituximab in CD20‐positive diffuse large B‐cell non‐Hodgkin's lymphoma

Non‐myeloablative allogeneic haematopoietic cell transplantation for relapsed diffuse large B‐cell lymphoma: a multicentre experience

Tumor flare reaction in a patient with mycosis fungoides treated with a novel immune-epigenetic doublet

Pretransplantation [18‐F]fluorodeoxyglucose positron emission tomography scan predicts outcome in patients with recurrent Hodgkin lymphoma or aggressive non‐Hodgkin lymphoma undergoing reduced‐intensity conditioning followed by allogeneic stem cell transplantation

Dose-escalated CHOP and tailored intensification with IFE according to early response and followed by BEAM/autologous stem-cell transplantation in poor-risk aggressive B-cell lymphoma: a prospective study from the GEL-TAMO Study Group

High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy

Burkitt‐like lymphoma with 11q aberration

Childhood aggressive B‐cell non‐Hodgkin lymphoma in low–middle‐income countries

Diffuse large B-cell lymphoma with involvement of the kidney: outcome and risk of central nervous system relapse

Recurrent mantle cell lymphoma in the uterine cervix: a case report

Favourable outcome of pneumonia due to novel influenza A/H1N1 2009 virus in a splenectomised adult patient undergoing therapy for non‐Hodgkin lymphoma

Clinical characteristics and outcome of isolated extracerebral relapses of primary central nervous system lymphoma: a case series

EXABS-140-LYM High Grade B-Cell Lymphoma: Pathologic Classification and Treatment Recommendations

combined evaluation of interim contrast-enhanced computerized tomography (CT) and FDG-PET/CT predicts the clinical outcomes and may impact on the therapeutic plans in patients with aggressive non-Hodgkin's lymphoma

CyclOBEAP (cyclophosphamide, vincristine, bleomycin, etoposide, doxorubicin, prednisolone) regimen with granulocyte colony-stimulating factor (G-CSF) for patients with aggressive non-Hodgkin's lymphoma: a pilot study

ALK-positive large B-cell lymphomas: A clinicopathologic study

The role of hematopoietic SCT in adult Burkitt lymphoma

The SYK inhibitor: a novel agent for improved outcomes in relapsed/refractory diffuse large B-cell lymphoma

Z-BeEAM (Ibritumomab tiuxetan, Bendamustine, Etoposide, Cytarabine, Melphalan) before autologous stem cell transplantation is safe and efficient for refractory large B-cell lymphoma

Aktive Filter

Suchergebnisse filtern